Bosch-Calvet M, Perez-Venteo A, Cebria-Xart A, Garcia-Cajide M, Mauvezin C
Biol Cell. 2025; 117(2):e12001.
PMID: 40012191
PMC: 11865694.
DOI: 10.1111/boc.12001.
Waldherr A, Fogtman A
Mol Med. 2025; 31(1):69.
PMID: 39979866
PMC: 11844092.
DOI: 10.1186/s10020-025-01081-0.
Nie A, Xiao Z, Deng J, Li N, Hao L, Li S
World J Gastrointest Oncol. 2025; 17(2):98556.
PMID: 39958554
PMC: 11755995.
DOI: 10.4251/wjgo.v17.i2.98556.
Karling T, Weavers H
EMBO Rep. 2025; 26(5):1238-1268.
PMID: 39915297
PMC: 11894099.
DOI: 10.1038/s44319-025-00381-0.
Kim S, Tsao H
Biomolecules. 2025; 15(1).
PMID: 39858514
PMC: 11763010.
DOI: 10.3390/biom15010120.
Chromosome mis-segregation triggers cell cycle arrest through a mechanosensitive nuclear envelope checkpoint.
Herve S, Scelfo A, Bersano Marchisio G, Grison M, Vaidziulyte K, Dumont M
Nat Cell Biol. 2025; 27(1):73-86.
PMID: 39779939
PMC: 11735390.
DOI: 10.1038/s41556-024-01565-x.
Chk2 sustains PLK1 activity in mitosis to ensure proper chromosome segregation.
Black E, Ramirez Parrado C, Trier I, Li W, Joo Y, Pichurin J
Nat Commun. 2024; 15(1):10782.
PMID: 39737931
PMC: 11685634.
DOI: 10.1038/s41467-024-54922-7.
Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform 'cold' tumors into 'hot' tumors.
Ying X, Chen Q, Yang Y, Wu Z, Zeng W, Miao C
Mol Cancer. 2024; 23(1):277.
PMID: 39710707
PMC: 11664935.
DOI: 10.1186/s12943-024-02186-6.
The Tumour Microenvironment and Epigenetic Regulation in Pathogenic Variant-Associated Breast Cancers.
Tay J, Ho J, Cheo F, Iqbal J
Cancers (Basel). 2024; 16(23).
PMID: 39682099
PMC: 11639800.
DOI: 10.3390/cancers16233910.
Origin of Chromosome 12 Trisomy Surge in Human Induced Pluripotent Stem Cells (iPSCs).
Narozna M, Latham M, Gorbsky G
bioRxiv. 2024; .
PMID: 39677655
PMC: 11642788.
DOI: 10.1101/2024.12.02.626470.
Cancer nuclear envelope rupture and repair in taxane resistance.
Xu A, Xu L, Smith E, Fleishman J, Chen Z, Xu X
Med Rev (2021). 2024; 4(6):522-530.
PMID: 39664077
PMC: 11629310.
DOI: 10.1515/mr-2024-0019.
TPR is required for cytoplasmic chromatin fragment formation during senescence.
Bartlett B, Kumar Y, Boyle S, Chowdhury T, Quintanilla A, Boumendil C
Elife. 2024; 13.
PMID: 39625470
PMC: 11666244.
DOI: 10.7554/eLife.101702.
When do the pathological signs become evident? Study of human mesenchymal stem cells in MDPL syndrome.
Paola S, Lara G, Michela M, Silvia D, Serena M, Rosalba P
Aging (Albany NY). 2024; 16(22):13505-13525.
PMID: 39611849
PMC: 11723661.
DOI: 10.18632/aging.206159.
Chromothripsis in cancer.
Simovic-Lorenz M, Ernst A
Nat Rev Cancer. 2024; 25(2):79-92.
PMID: 39548283
DOI: 10.1038/s41568-024-00769-5.
Genomic instability as a driver and suppressor of anti-tumor immunity.
Requesens M, Foijer F, Nijman H, de Bruyn M
Front Immunol. 2024; 15:1462496.
PMID: 39544936
PMC: 11562473.
DOI: 10.3389/fimmu.2024.1462496.
Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma.
Liu X, Wang Y, Wang C, Wang X, Tang G, Xiong Z
Front Oncol. 2024; 14:1469833.
PMID: 39512768
PMC: 11540661.
DOI: 10.3389/fonc.2024.1469833.
Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?.
Xu C, Jing W, Liu C, Yuan B, Zhang X, Liu L
Front Immunol. 2024; 15:1343325.
PMID: 39450183
PMC: 11499118.
DOI: 10.3389/fimmu.2024.1343325.
High prevalence of chromosome 17 in breast cancer micronuclei: a means to get rid of tumor suppressors?.
Kumari L, Sreedharanunni S, Dahiya D, Dey P, Bhatia A
Hum Cell. 2024; 38(1):5.
PMID: 39438374
DOI: 10.1007/s13577-024-01143-1.
A new microscopy pipeline for studying the initial stages of nuclear and micronuclear rupture and repair.
Di Bona M, Bakhoum S
Front Cell Dev Biol. 2024; 12:1475095.
PMID: 39359718
PMC: 11445188.
DOI: 10.3389/fcell.2024.1475095.
RCC1 depletion drives protein transport defects and rupture in micronuclei.
Zych M, Contreras M, Vashisth M, Mammel A, Ha G, Hatch E
bioRxiv. 2024; .
PMID: 39282444
PMC: 11398501.
DOI: 10.1101/2024.09.04.611299.